NORTHWEST BIOTHERAPEUTICS INC Operating Lease, Right-of-Use Asset, Amortization Expense
NORTHWEST BIOTHERAPEUTICS INC (NWBO) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $154.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-14
- NORTHWEST BIOTHERAPEUTICS INC operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $78.00K, a 18.18% increase year-over-year.
- NORTHWEST BIOTHERAPEUTICS INC operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $76.00K, a 18.75% increase year-over-year.
- NORTHWEST BIOTHERAPEUTICS INC operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $73.00K, a 14.06% increase year-over-year.
- NORTHWEST BIOTHERAPEUTICS INC operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $70.00K, a 9.09% decline year-over-year.
- NORTHWEST BIOTHERAPEUTICS INC operating lease, right-of-use asset, amortization expense for fiscal 2025 was $273.00K, a 9.00% decline from fiscal 2024.
- NORTHWEST BIOTHERAPEUTICS INC operating lease, right-of-use asset, amortization expense for fiscal 2024 was $300.00K.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $78.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $154.00K 10-Q · filed 2026-08-14 | $227.00K derived: sum of 3 quarters · filed 2026-08-14 | $297.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $76.00K 10-Q · filed 2026-05-15 | $149.00K derived: sum of 2 quarters · filed 2026-05-15 | $219.00K derived: sum of 3 quarters · filed 2026-05-15 | $285.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $73.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $143.00K derived: sum of 2 quarters · filed 2026-04-15 | $209.00K derived: sum of 3 quarters · filed 2026-08-14 | $273.00K 10-K · filed 2026-04-15 |
| 2025-09-30 | $70.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $136.00K derived: sum of 2 quarters · filed 2026-08-14 | $200.00K 10-Q · filed 2025-11-14 | $264.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $66.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $130.00K 10-Q · filed 2026-08-14 | $194.00K derived: sum of 3 quarters · filed 2026-08-14 | $271.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $64.00K 10-Q · filed 2026-05-15 | $128.00K derived: sum of 2 quarters · filed 2026-05-15 | $205.00K derived: sum of 3 quarters · filed 2026-05-15 | $287.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $64.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $141.00K derived: sum of 2 quarters · filed 2026-04-15 | $223.00K derived: sum of 3 quarters · filed 2026-04-15 | $300.00K 10-K · filed 2026-04-15 |
| 2024-09-30 | $77.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $159.00K derived: sum of 2 quarters · filed 2025-11-14 | $236.00K 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $82.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $159.00K 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | $77.00K 10-Q · filed 2025-05-15 | |||
| 2023-09-30 | $73.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $144.00K derived: sum of 2 quarters · filed 2024-11-12 | $211.00K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $71.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $138.00K 10-Q · filed 2024-08-09 | ||
| 2023-03-31 | $67.00K 10-Q · filed 2024-05-10 | |||
| 2022-09-30 | $63.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $184.00K 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | $121.00K 10-Q · filed 2023-08-09 |